|
Market Closed -
Deutsche Boerse AG
15:41:56 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 3.202 EUR | -3.44% |
|
-3.90% | -41.36% |
| 09-02 | Evotec, Plectonic Launch Research Collaboration on New T-Cell Approaches for Solid Tumors | MT |
| 09-02 | Evotec, Plectonic Biotech Partner on Research of Novel Immunotherapy for Solid Tumors | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 48.93B | |||||
| 45.01B | - | - | - | - | - |
| 44.07B | |||||
| 40.73B | |||||
| 33.52B |
- Stock Market
- Stocks
- EVT Stock
- EVT Stock
- Charts Evotec SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
